CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

Takeda has ended development of its nausea and vomiting drug candidate for strategic reasons, continuing its multi-year ...

Inch by inch, Siraj's health rebounded. He credits those around them for their unwavering support. In February 2023, Siraj had a moment that would be insignificant to most. But taking a step back, ...

AIIMS New Delhi's Neurobiochemistry laboratory launches advanced Therapeutic Drug Monitoring facility for epilepsy patients ...

IVIG may reduce seizure frequency in some children with drug-resistant epilepsy, especially those with generalized seizures.

A debilitating infection took away a Georgia teen’s ability to talk, or even walk, for more than a year.

Stricken pair thought to be first in China to fall ill with debilitating condition at same time; disorder may have come from ...

In a condition known as "IgLON5 encephalitis," the immune system mistakenly attacks cells in the brain. This leads to brain ...

A young married couple were diagnosed with a rare autoimmune disorder within months of each other after developing severe ...